SCHEMBL5508602

SCHEMBL5508602

CN(C)c1cccc2c(S(=O)(=O)N(CCCN)CCCCN)cccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.64
CYP2C19 P33261 1/20 0.64
HTT P42858 1/20 0.64
HIF1A Q16665 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
CA2 P00918 1/20 0.55
F2 P00734 3/20 0.51
PRSS1 P07477 3/20 0.51
PRSS2 P07478 3/20 0.51
PRSS3 P35030 3/20 0.51
HDAC6 Q9UBN7 3/20 0.51
HDAC3 O15379 3/20 0.51
HDAC1 Q13547 3/20 0.51
HDAC2 Q92769 3/20 0.51
NCOR2 Q9Y618 3/20 0.51
EDNRA P25101 5/20 0.46
KMT2A Q03164 1/20 0.45
ATM Q13315 1/20 0.45
HDAC4 P56524 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5517949 0.91 CYP1A2 (0.56) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL19270962 0.89 CYP1A2 (0.71) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL6412206 0.85 CYP1A2 (0.70) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL8532341 0.85 CYP1A2 (0.74) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL30275401 0.85 CYP1A2 (0.74) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL13713847 0.83 CYP1A2 (0.71) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL19270960 0.82 CYP1A2 (0.78) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL6416698 0.81 CA2 (0.57) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL13067413 0.81 CYP1A2 (0.60) CYP1A2CYP2C19HTTHIF1ATDP1
SCHEMBL9752647 0.80 CYP1A2 (0.54) CYP1A2CYP2C19HTTHIF1ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1867633-A1 Polyamine analogues as therapeutic and diagnostic agents MediQuest Therapeutics, Inc. (US) 2007-12-19 EP disclosed
EP-1001927-A2 NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS ORIDIGM CORPORATION (US) 2000-05-24 EP disclosed
WO-1999003823-A2 NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS ORIDIGM CORPORATION (US) 1999-01-28 WO disclosed